Cancer Research AACR Legacy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1833-1838, May 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, A.
Right arrow Articles by Kamataki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, A.
Right arrow Articles by Kamataki, T.

Establishment of a Salmonella Tester Strain Highly Sensitive to Mutagenic Heterocyclic Amines1

Akihiro Suzuki, Hirotaka Kushida, Hiroshi Iwata, Masahiko Watanabe, Takehiko Nohmi, Ken-ichi Fujita, Frank J. Gonzalez and Tetsuya Kamataki2

Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo-shi, 060, Japan [A. S., H. K., H. I., K-i. F., T. K.]; Division of Biochemicals, National Cancer Center Reserch Institute, Tokyo, 104, Japan [M. W.]; Division of Genetics and Mutagenesis, National Institute of Health Sciences, Tokyo, 158, Japan [T. N.]; and Laboratory of Metabolism, NIH, Bethesda, Maryland 20892 [F. J. G.]

Heterocyclic amines (HCAs) that are present in cooked foods require metabolic activation to exert their genotoxicity. They undergo activation via N-hydroxylation by cytochrome P450 1A2 (CYP1A2), followed by O-esterification by O-acetyltransferase (OAT). To develop a Salmonella tester strain that is highly sensitive to mutagenic HCAs, we introduced a coexpression plasmid (p1A2OR) carrying human (CYP1A2 and NADPHCYP reductase cDNAs and an expression plasmid (pOAT) carrying Salmonella OAT to Salmonella typhimurium TA1538 to yield a TA1538/ARO strain. The TA1538/ARO strain was proven to express the enzymes, as indicated by high activities of 7-ethoxyresorufin O-deethylase and isoniazid N-acetylase.

The TA1538/ARO strain exhibited very high sensitivity tomutagenic HCAs 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and a somewhat higher sensitivity to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine compared with the parent Ames tester strain TA1538. The minimum concentrations of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, IQ, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine giving positive results were defined by evidence that the number of colonies increased in a dose-dependent manner and reached a number two times higher than that obtained by vehicle alone as a control in the TA1538/ARO strain at concentrations of 0.3, 3, 30, and 1000 pM, respectively. When the membrane and cytosol fractions prepared from TA1538/ARO were added to a mixture containing the parental TA1538, the sensitivity of TA1538 to IQ was much lower than that seen with TA1538/ARO. These results indicate that the intracellular expression of drug-metabolizing enzymes makes the established strain of Salmonella highly sensitive to mutagenic HCAs.

1 Supported by the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Drug ADR Relief, Research and Development Promotion and Product Review, Japan. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture, Japan.

2 To whom requests for reprints should be addressed, at Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, N12 W6 Kita-ku, Sapporo-shi, 060-0812, Japan. Phone/Fax: 81-11-706-4978; E-mail: kamataki@pharm.hokudai.ac.jp.

Received 10/ 6/97. Accepted 2/27/98.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. L. Miranda, Y.-H. Yang, M. C. Henderson, J. F. Stevens, G. Santana-Rios, M. L. Deinzer, and D. R. Buhler
Prenylflavonoids from Hops Inhibit the Metabolic Activation of the Carcinogenic Heterocyclic Amine 2-Amino-3-methylimidazo[4,5-f]quinoline, Mediated by cDNA-Expressed Human CYP1A2
Drug Metab. Dispos., November 1, 2000; 28(11): 1297 - 1302.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
F. P. Guengerich
Metabolism of chemical carcinogens
Carcinogenesis, March 1, 2000; 21(3): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Paladino, B. Weibel, and C. Sengstag
Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains
Carcinogenesis, November 1, 1999; 20(11): 2143 - 2152.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. A.J. Schut and E. G. Snyderwine
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Carcinogenesis, March 1, 1999; 20(3): 353 - 368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.